Skip to Content

Triamcinolone nasal Pregnancy and Breastfeeding Warnings

Triamcinolone nasal is also known as: Allernaze, Nasacort, Nasacort AQ, Nasacort Allergy 24HR, Nasacort HFA

Medically reviewed on October 30, 2017

Triamcinolone nasal Pregnancy Warnings

Triamcinolone has been assigned to pregnancy category C by the FDA. At high doses, triamcinolone has been shown to be teratogenic in rabbits, rats, and monkeys. There are no controlled data in human pregnancy. Triamcinolone is only recommended for use during pregnancy when there are no alternatives and benefit outweighs risk.

See references

Triamcinolone nasal Breastfeeding Warnings

There are no data on the excretion of triamcinolone into human milk. However, other glucocorticoids are excreted into human milk in low concentrations. The manufacturer recommends that caution be used when administering triamcinolone to nursing women.

See references

References for pregnancy information

  1. "Product Information. Nasacort (triamcinolone nasal)." Rhone-Poulenc Rorer, Collegeville, PA.

References for breastfeeding information

  1. "Product Information. Nasacort (triamcinolone nasal)." Rhone-Poulenc Rorer, Collegeville, PA.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide